Corporate news

Grifols PhocusRx Certified DIACAP Compliant The PhocusRx system can operate with a low and acceptable level of risk when installed in a Department of Defense facility that meets security requirements.
+ info

SIPPET Study on inhibitors in Hemophilia A: interim analysis confirms the original hypothesis The Study is safe to continue after Investigators' Meeting and the disclosure of interim analysis in San Francisco
+ info



We are a solid company with an international dimension.

Corporate Commitment

We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.

New transfusion medicine solutions

Grifols is committed to helping you work efficiently to deliver blood that is safe and compatible for patients. + info


get to know us better